|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.12 SGD | +50.00% |
|
+50.00% | +22.45% |
| Apr. 15 | Pharmesis’ Attributable Loss for 2023 Widens | MT |
| Apr. 15 | Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director | CI |
Pharmesis International Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 50.37 million compared to CNY 52.77 million a year ago. Net loss was CNY 3.56 million compared to net income of CNY 1.17 million a year ago.
Basic loss per share from continuing operations was CNY 0.155 compared to basic earnings per share from continuing operations of CNY 0.051 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +22.45% | 2.43M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PHARMESIS INTERNATIONAL LTD. 
